Highlights from the November 2022 Issue
The entire November issue is FREE until November 30th in celebration of Kidney Week
Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. From the November 2022 issue:
Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study by James B. Wetmore et al
From the authors: Some patients on dialysis who have atrial ﬁbrillation receive apixaban for stroke prevention at a dose below that indicated by the ofﬁcial drug label to reduce adverse bleeding events. Using US Renal Data System data, we compared apixaban dosed according to the label, apixaban dosed below the label, and warfarin to assess each regimen’s association with stroke prevention, major bleeding, and death. We found that apixaban, regardless of dosing strategy, was associated with a lower risk of major bleeding than warfarin. When dosed in accordance with the label, apixaban appears to be associated with a lower risk of death compared with warfarin. There were no differences in stroke prevention among any of the 3 treatment approaches. Apixaban dosed in accordance with the label may provide the most favorable beneﬁt-risk trade-off in dialysis patients with atrial ﬁbrillation.
Editorial: Anticoagulation for Stroke Prevention in Atrial Fibrillation by Nicolas Krepostman and Holly J. Kramer [FREE]
Efficacy of Potassium Supplementation in Hypokalemic Patients Receiving Peritoneal Dialysis: A Randomized Controlled Trial by Watthikorn Pichitporn et al
From the authors: Hypokalemia, which is commonly found in patients on peritoneal dialysis (PD), is associated with poor out-comes. A multicenter, open-label, prospective, randomized controlled trial was conducted with 167 hypokalemic patients receiving PD. It examined whether a protocol-based correction of hypokalemia to maintain a serum potassium concentration of 4-5 mEq/L (85 participants) could improve PD-related outcomes compared with reactive potassium supplementation administered when serum potassium levels fell below 3.5 mEq/L (82 participants). During the median follow-up time of 401 days, the protocol supplementation appeared safe and signiﬁcantly reduced the risk of peritonitis.
Editorial: Correction of Hypokalemia in Peritoneal Dialysis Patients May Decrease Peritonitis Risk by Beth M. Piraino [FREE]
Association Between Ultraprocessed Food Consumption and Risk of Incident CKD: A Prospective Cohort Study by Shotung Du et al
From the authors: Ultraprocessed foods are industrially processed foods and drinks that contain little to no intact foods and mostly consist of artificial substances and additives. The consumption of ultraprocessed foods has been increasing around the world recently and has been linked with adverse health outcomes. In this study, we aimed to expand the evidence by investigating the relationship between ultraprocessed foods consumption and risk of chronic kidney disease. We found that the higher consumption of ultraprocessed foods is associated with higher risk of chronic kidney disease. Our results provided support to avoid ultraprocessed foods, and further studies should explore the underlying mechanisms by which ultraprocessed foods may be harmful to the kidneys.
Editorial: Nutrition and Kidney Health: Processing Emerging Evidence About Foods by Cheryl A.M. Anderson and Titilayo Ilori [FREE]
Shared Decision Making Among Older Adults With Advanced CKD by Rebecca Frazier et al [OPEN ACCESS]
From the authors: Older adults with advanced kidney disease face difﬁcult treatment decisions. Dialysis offers uncertain survival beneﬁts but has signiﬁcant quality of life implications. Shared decision making (SDM) may help patients choose treatment options that best align with their goals and values. We performed a cross-sectional analysis among older adults with advanced kidney disease to examine SDM in nephrology clinics using the 9-item Shared Decision Making Questionnaire. We found that SDM was suboptimal, with a mean questionnaire score of 52 (possible scores of 0-100). Being “well informed” and “very well informed” about kidney treatment options, having higher decisional certainty, and attendance at a kidney treatment options class were associated with greater SDM. Our research highlights the need to improve SDM for older adults facing dialysis decisions.
Black and White Adults With CKD Hospitalized With Acute Kidney Injury: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study by Anthony N. Muiru et al
From the authors: Although much is known about racial disparities in kidney failure, few studies have investigated Black and White racial differences in acute kidney injury (AKI). We examined whether Black participants in the Chronic Renal Insufﬁciency Cohort (CRIC) Study were at an increased risk of AKI compared with White study participants, after accounting for differences in prehospitalization clinical risk factors, socioeconomic status, and genetic risk factors. We found that Black participants had a greater risk of AKI than White participants, but this elevated risk was modest and was explained by differences in prehospitalization clinical risk factors such as proteinuria, hypertension, diabetes, and heart failure. These ﬁndings suggest that targeted screening and aggressive management of these clinical risk factors may reduce the risk of AKI.
Maternal Chronic Disease and Congenital Anomalies of the Kidney and Urinary Tract in Offspring: A Japanese Cohort Study by Kei Nishiyama et al [OPEN ACCESS]
From the authors: Prior studies reported that several maternal chronic diseases are associated with congenital anomalies of the kidney and urinary tract (CAKUT) in offspring without distinguishing isolated cases of CAKUT from those complicated by extrarenal anomalies. By studying the prospective cohort of the Japan Environment and Children’s Study, we were able to examine the association of maternal diseases with isolated and complicated CAKUT. We found that the risk of isolated CAKUT was increased in children of mothers who experienced kidney disease or cancer, whereas complicated CAKUT was more common in children of mothers with diabetes mellitus. These ﬁndings provide insights that may inform the management of pregnancy and highlight potential differences in the genesis of isolated and complicated forms of CAKUT.
Preoperative Ionized Magnesium Levels and Risk of Acute Kidney Injury After Cardiac Surgery by Hee Byung Koh et al
From the authors: Kidney damage that occurs after heart surgery is a serious complication, but preventive measures are limited. In this study investigating large groups of patients from 2 tertiary hospitals, patients with lower blood magnesium levels were more likely to develop kidney damage after heart surgery. In addition, the probability of kidney damage increased in a stepwise manner with decreasing blood magnesium levels before surgery. These relationships were maintained regardless of other factors that could affect kidney health. These results suggest that testing blood magnesium levels before surgery may assist in the identiﬁcation of patients who are likely to develop kidney damage after heart surgery.
Association of Long-term Ambient Fine Particulate Matter (PM2.5) and Incident CKD: A Prospective Cohort Study in China by Jing-wen Duan et al [OPEN ACCESS]
From the authors: Exposure to a form of air pollution known as ﬁne particulate matter (ie, particulate matter ≤2.5 μm [PM2.5]) has been linked to an increased risk of chronic kidney disease (CKD), but little is known about how PM2.5 affects CKD in regions with extremely high levels of PM2.5 pollution. This longitudinal cohort study in China investigates the effect of PM2.5 on the incidence of CKD and whether temperature or humidity interact with PM2.5. Our ﬁndings suggest that long-term expo-sure to high levels of ambient PM2.5 signiﬁcantly increased the risk of CKD in mainland China, especially in terms of cumulative average PM2.5. The associations of PM2.5 and incident CKD were greater in high-humidity environments. These ﬁndings support the recommendation that reducing PM2.5 pollution should be a priority to decrease the burden of associated health risks, including CKD.
Association Between Long-term Ambient PM2.5 Exposure and Cardiovascular Outcomes Among US Hemodialysis Patients by Yuzhi Xi et al [OPEN ACCESS]
From the authors: Long-term exposure to air pollution, also called PM2.5, has been linked to adverse cardiovascular outcomes. However, little is known about the association of PM2.5 and outcomes among patients receiving dialysis, who are individuals with high cardiovascular disease burdens. We conducted an epidemiological study to assess the association between the annual PM2.5 exposure and cardiovascular events and death among patients receiving regular outpatient hemodialysis in the United States between 2011 and 2016. We found a higher risk of heart attacks, strokes, and related events in patients exposed to higher levels of air pollution. Stronger associations between air pollution and adverse health events were observed among patients who were older at the start of dialysis, had chronic obstructive pulmonary disease, or were Asian. These ﬁndings bolster the evidence base linking air pollution and adverse health outcomes and may inform policy makers and clinicians.
Review from the November 2022 Issue:
Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms by Murray Epstein et al (FREE)
From the authors: Mineralocorticoid receptor (MR) activation is involved in propagating kidney injury, inflammation, and fibrosis and in the progression of chronic kidney disease (CKD). Multiple clinical studies have defined the efficacy of MR antagonism in attenuating progressive kidney disease, and the US Food and Drug Administration recently approved the nonsteroidal mineralocorticoid receptor antagonist (MRA) finerenone for this indication. In this review, we consider the basic science and clinical applicability of MR antagonism. Because hyperkalemia constitutes a constraint to implementing evidence-based MR blockade, we review MRA-associated hyperkalemia in the context of finerenone and discuss evolving mitigation strategies to enhance the safety and efficacy of this treatment. Although the FIDELIO-DKD and FIGARO-DKD clinical trials focused solely on patients with type 2 diabetes mellitus, we propose that MR activation and the resulting inflammation and fibrosis act as a substantive pathogenetic mediator not only in people with diabetic CKD but also in those with CKD without diabetes. We close by briefly discussing both recently initiated and future clinical trials that focus on extending the attributes of MR antagonism to a wider array of nondiabetic kidney disorders, such as patients with nonalbuminuric CKD.
On the Cover: In this NASA satellite photo from late 2013, eastern China, home to the capital city of Beijing, is obscured by a thick, gray haze. During that time, the air pollution levels of PM2.5 (a measurement of fine particulate matter of less than 2.5 microns in width suspended in the air) in Beijing was nearly 20 times higher than the amount recommended by the World Health Organization. In this issue of AJKD, 2 studies demonstrate links between high PM2.5 levels and adverse clinical outcomes. Duan et al show that higher PM2.5 levels are associated with higher risk of incident CKD in China. Xi et al show that higher PM2.5 levels are associated with higher risk of cardiovascular events and death among patients receiving hemodialysis in the United States Measures aimed at reducing air pollution may help improve health outcomes.
The photograph “Haze over eastern China” by NASA/GSFC/Jeff Schmaltz/MODIS Land Rapid Response Team is released on Flickr under the CC BY 2.0 license
Special Collection: Pregnancy and Kidney Disease (FREE until Dec 11, 2022)
This Special Collection features articles on pregnancy and kidney disease published in AJKD over the past four years. These articles highlight the research and advances in knowledge regarding the clinical care for people with kidney disease with the capacity for pregnancy. Kidney disease poses significant risks for both birthing parent and fetus during pregnancy and pregnancy heightens the risk for kidney disease progression and kidney failure. We hope the article collection provides nephrologists relevant information for this timely topic.
Leave a Reply